14.55
Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
29.76%
4.0216
|
5.7258 | 7.945 | 4.1746 | 4.046 |
| Operating Income/Loss |
29.76%
-4.0216
|
-5.7258 | -7.945 | -4.1746 | -4.046 |
|
|
30.20%
-3.9487
|
-5.6571 | -7.9227 | -4.1518 | -4.0253 |
| Basic Average Shares |
0.38%
14.62
|
14.57 | - | 13.64 | 13.37 |
| Diluted Average Shares |
0.38%
14.62
|
14.57 | - | 13.64 | 13.37 |
| Basic Earnings Per Share |
30.77%
-0.27
|
-0.39 | - | -0.30 | -0.30 |
| Diluted Earnings Per Share |
30.77%
-0.27
|
-0.39 | - | -0.30 | -0.30 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):